Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Carcinoma × Radiation × Clear all

Phase

Status

Completed 2 Active not recruiting 2 Unknown 1 Suspended 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 2 Glioblastoma 2 Esophageal Neoplasms 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Oropharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Meningioma 1 Lung Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Adrenocortical Carcinoma 1

Interventions

Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Magnetic Resonance Spectroscopy 2 Cetuximab 2 selinexor 1 ponatinib 1 poly ICLC 1 pemigatinib 1 neratinib 1 fludarabine phosphate 1 fludarabine 1 donafenib 1 cobimetinib 1 ceritinib 1 cemiplimab 1 brigatinib 1 abemaciclib 1 Thymopentin 1 Taxes 1 Surgical Procedures, Operative 1 Standard of Care 1 Radiosurgery 1 Radiation 1 Paclitaxel 1 Oxaliplatin 1 Nivolumab 1 Neck Dissection 1 NF protocol 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05144100 2021-12-03

SCOPE

Tata Memorial Centre

Phase 2/3 Not yet recruiting

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡